LekoskopLekoskop
EN All changes
Medicine recalls and shortages › New approvals › 21 Jul 2026
MHRA approval

world's first lower-carbon beclometasone inhalers

Published on 21 Jul 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment.

What this means

The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.

Summary

The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.